Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer

• Published in: Journal of breast cancer Vol. 24; no. 1; pp. 75 - 84
• Main Authors: Min, Seung Ki, Lee, Se Kyung, Woo, Jinsun, Jung, Sung Mi, Ryu, Jai Min, Yu, Jonghan, Lee, Jeong Eon, Kim, Seok Won, Chae, Byung Joo, Nam, Seok Jin
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Breast Cancer Society 01.02.2021; 한국유방암학회
• Subjects: Original; 일반외과학; Immunohistochemistry; Lymphatic metastasis; Breast neoplasms; Prognosis
• ISSN: 1738-6756; 2092-9900
• DOI: 10.4048/jbc.2021.24.e4

Tumor size and lymph node metastasis are important factors that contribute to the progression of breast cancer. We aimed to analyze the relationship between tumor size and lymph node metastasis molecular subtype and examine the effects of nodal metastasis on overall survival (OS). We retrospectively reviewed the data of 16,552 patients who underwent breast surgery in Samsung Medical Center between 2000 and 2015. Information on tumor size (largest diameter of the invasive component), number of positive lymph nodes, and molecular subtype were obtained. We constructed a linear regression model to evaluate the relationship between tumor size and lymph node metastasis. To determine the effect of nodal metastasis on OS, we performed a Cox proportional regression analysis with Np/T (number of metastatic lymph nodes [n]/tumor size [cm]). This study included 12,007 patients with a median follow-up of 62 months. The linear regression coefficients were 1.043 for luminal A, 1.024 for luminal B, 0.656 for HER2, and 0.435 for triple-negative breast cancer (TNBC) subtypes. No significant difference was observed in the coefficients between the luminal A and B subtypes ( =0.797), while all other coefficients showed significant difference. After adjusting for other risk factors, the hazard ratio (HR) of Np/T for each subtype was significant for OS: luminal A (HR, 1.134; 95% confidence interval [CI], 1.097-1.171; < 0.001), luminal B (HR, 1.049; 95% CI, 1.013-1.086; =0.007), HER2 (HR, 1.069; 95% CI, 1.014-1.126; =0.013), and TNBC (HR, 1.038; 95% CI, 1.01-1.067; =0.008). The incidence of lymph node metastasis differed according to molecular subtype. Luminal types have higher incidence of nodal metastasis than HER2 and TNBC. The HR of Np/T was highest in luminal A subtypes and lowest in TNBC subtypes.